ArticleBiosensors2025
Evaluating the Performance of Hyperspectral Imaging Endoscopes: Mitigating Parameters Affecting Spectral Accuracy.
Article in Biosensors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Emerging non-invasive tools for hair follicle assessment: a narrative review on hyperspectral and terahertz imaging.Lasers in medical science · 2026Review
- Optical Spectroscopy and Spectral Imaging for Bladder Cancer Detection and Characterisation: A Scoping Review of Diagnostic Evidence and Translational Readiness.Diagnostics (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Hyperspectral imaging (HSI) is increasingly used in studies for medical applications as it provides both structural and functional information of biological tissue, enhancing diagnostic accuracy and clinical decision-making. Recently, HSI cameras (HSICs) have been integrated with medical endoscopes (HSIEs), capturing hypercube data beyond conventional white light imaging endoscopes. However, there are currently no cleared or approved HSIEs by the U.S. Food and Drug Administration (FDA). HSI accuracy depends on technologies and experimental parameters, which must be assessed for reliability. Importantly, the reflectance spectrum of a target can vary across different cameras and under different environmental or operational conditions. Thus, before reliable clinical translation can be achieved, a fundamental question must be addressed: can the same target yield consistent spectral measurements across different HSI systems and under varying acquisition conditions? This study investigates the impact of eight parameters-ambient light, exposure time, camera warm-up time, spatial and temporal averaging, camera focus, working distance, illumination angle, and target angle-on spectral measurements using two HSI techniques: interferometer-based spectral scanning and snapshot. Controlled experiments were conducted to evaluate how each parameter affects spectral accuracy and whether normalization can mitigate these effects. Our findings reveal that several parameters significantly influence spectral measurements, with some having a more pronounced impact. While normalization reduced variations for most parameters, it was less effective at mitigating errors caused by ambient light and camera warm-up time. Additionally, normalization did not eliminate spectral noise resulting from low exposure time, small region of interest, or a spectrally non-uniform light source. From these results, we propose practical considerations for optimizing HSI system performance. Implementing these measures can minimize variations in reflectance spectra of identical targets captured by different cameras and under diverse conditions, thereby supporting the reliable translation of HSI techniques to clinical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.